Skip to main content
. 2020 Feb 28;9(2):1058–1064. doi: 10.4103/jfmpc.jfmpc_898_19

Table 2.

Knowledge and attitudes of the participants according to academic year

KAP Statements Overall n (%) (n=153) Academic year P§

4th year n (%) (n=73) 5th year n (%) (n=80)
Knowledge
K1. What is the estimated prevalence of DR for a patient with DM?
 20% 31 (20.3%) 08 (11.0%) 23 (28.8%) 0.020 **
 40% 99 (64.7%) 54 (74.0%) 45 (56.2%)
 70% 23 (15.0%) 11 (15.1%) 12 (15.0%)
K2. DR is a disease of:
 optic nerves 32 (20.9%) 23 (31.5%) 09 (11.2%) 0.002 **
 blood vessels 119 (77.8%) 48 (65.8%) 71 (88.8%)
 increased intra-ocular pressure 02 (01.3%) 02 (02.7%) 0
K3. The most critical risk factor in developing DR in a patient with DM is:
 duration of DM 124 (81.0%) 56 (76.7%) 68 (85.0%) 0.278
 hypertension 20 (13.1%) 10 (13.7%) 10 (12.5%)
 pregnancy 01 (0.70%) 01 (01.4%) 0
 nephropathy 08 (05.2%) 06 (08.2%) 02 (02.5%)
K4. The risk of developing DR is reduced through:
 optimizing glycemic control 36 (23.5%) 10 (13.7%) 26 (32.5%) 0.021 **
 optimizing blood pressure control 03 (02.0%) 02 (02.7%) 01 (01.2%)
 both 114 (74.5%) 61 (83.6%) 53 (66.2%)
K5. The most common cause of gradual and chronic visual impairment in patients with DM is:
 diabetes-related macular edema 123 (80.4%) 63 (86.3%) 60 (75.0%) 0.056
 vitreous hemorrhage 25 (16.3%) 10 (13.7%) 15 (18.8%)
 cataract surgery 05 (03.3%) 0 05 (06.2%)
K6. An initial dilated and comprehensive ophthalmic examination of a patient with DM should be undertaken for:
 patients with type I DM at diagnosis and for patients with type II DM 5 years post-diagnosis 37 (24.2%) 12 (16.4%) 25 (31.2%) <0.001 **
 patients with type I DM 5 years post-diagnosis and for patients with type II DM at the time of diagnosis 85 (55.6%) 54 (74.0%) 31 (38.8%)
 patients with either type I or type II DM at time of diagnosis 23 (15.0%) 02 (02.7%) 21 (38.8%)
 patients with either type I or type II DM 5 years post-diagnosis 08 (05.2%) 05 (06.8%) 03 (03.8%)
Attitudes
A1. A patient with DM should have a regular ophthalmic examination.
 agree 152 (99.3%) 73 (100%) 79 (98.8%) 0.338
 disagree 01 (0.7%) 0 01 (01.2%)
A2. There is no need for a patient to visit an ophthalmologist if their DM is well-controlled
 agree 11 (07.2%) 06 (08.2%) 05 (06.2%) 0.559
 disagree 123 (80.4%) 60 (82.2%) 63 (78.8%)
 undecided 19 (12.4%) 07 (09.6%) 12 (15.0%)
A3. Does timely treatment of DM decrease/prevent DR?
 agree 121 (79.1%) 63 (86.3%) 58 (72.5%) 0.111
 disagree 22 (14.4%) 07 (09.6%) 15 (18.8%0
 undecided 10 (06.5%) 03 (04.1%) 07 (08.8%)
A4. Patients with DM often waste time and money undertaking eye check-up as most of the time their eyes are healthy
 agree 14 (09.2%) 10 (13.7%) 04 (05.0%) 0.172
 disagree 107 (69.9%) 49 (67.1%) 58 (72.5%)
 undecided 32 (20.9%) 14 (19.2%) 18 (22.5%)

DM, diabetes mellitus; DR, diabetes-related retinopathy; KAP, knowledge, attitudes, and practices, Signifies the correct answer. Signifies a negative answer. §The P value was calculated using a Chi-square test. ** Significance at P≤0.05